| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Liquidia Corporation (LQDA) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. LQDA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.14M | $626.05M | - | |
| CEO | 1.05M | $80.62M | - | |
| Dir | 880.1K | $67.70M | -100,000 | |
| Other | 579.4K | $44.57M | - | |
| Other | 214.3K | $16.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Adair Jason | Chief Business Officer | Sale+OE | 455 | $11.51 | $5,237.05 | -0.4% | +32.4% | +174.2% | |
| Oct 28, 2024 | Adair Jason | Chief Business Officer | Sell | 459 | $11.31 | $5,190.42 | -0.4% | +27.0% | +109.9% | |
| Oct 18, 2024 | Saggar Rajeev | Chief Medical Officer | Sell | 2,526 | $11.19 | $28,265.94 | -1.2% | +12.3% | +101.8% | |
| Oct 14, 2024 | Schundler Russell58 | General Counsel | Sell | 2,576 | $11.11 | $28,613.44 | -0.5% | +5.6% | +104.5% | |
| Oct 14, 2024 | Saggar Rajeev | Chief Medical Officer | Sell | 2,260 | $11.11 | $25,103.40 | -1.1% | +5.6% | +104.5% | |
| Oct 14, 2024 | Moomaw Scott | Chief Commercial Officer | Sell | 1,527 | $11.11 | $16,961.46 | -1.0% | +5.6% | +104.5% | |
| Oct 14, 2024 | Kaseta Michael57 | CFO And COO | Sell | 3,892 | $11.11 | $43,231.17 | -1.2% | +5.6% | +104.5% | |
| Oct 14, 2024 | Jeffs Roger66 | Chief Executive Officer | Sell | 8,053 | $11.11 | $89,450.31 | -1.0% | +5.6% | +104.5% | |
| Oct 14, 2024 | Adair Jason | Chief Business Officer | Sale+OE | 1,146 | $11.11 | $12,729.42 | -1.0% | +5.6% | +104.5% | |
| Sep 12, 2024 | Manning Paul B54 | Director | Buy | 337,078 | $8.90 | $2,999,994.20 | +70.3% | +12.6% | +167.4% |